Clinical Trials Directory

Trials / Unknown

UnknownNCT05070962

Complex Post-traumatic Stress Disorder: What Symptomatological Specificities

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Raincy Montfermeil Hospital Group · Network
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A better understanding of the Complex Post-Traumatic Stress Disorder would allow a management as close as possible to the specificities of this one, but also a better training of professionals and adapted therapeutic indications.

Detailed description

Post-Traumatic Stress Disorder manifests itself in a multitude of symptoms and self-regulation difficulties in various domains (somatization and biological balance, attention and consciousness, regulation of affects and impulses, interpersonal relationships and relational capacities, perception of the aggressor and of the aggression, self-perception and identity, sense and belief system) as well as profound changes in personality and various comorbidities .In addition, dissociation, the origin and the resulting disorders also have some similarities to Complex Post-Traumatic Stress Disorder. Indeed, dissociation is thought to have a traumatic origin and the symptomatology (eg hyperesthesia, dissociative amnesia, anesthesia) is included in Complex Post-Traumatic Stress Disorder. We can then ask ourselves the following questions: is Complex Post-Traumatic Stress Disorder a dissociative disorder in its own right causing difficulties with self-regulation? What is the share of dissociation in Complex Post-Traumatic Stress Disorder?

Conditions

Interventions

TypeNameDescription
OTHERclinical populationor the general population, students of the University of Lille will be offered the opportunity to participate in a study through posters in the corridors of the faculties and announcements in the lecture halls.

Timeline

Start date
2021-02-17
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2021-10-07
Last updated
2021-10-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05070962. Inclusion in this directory is not an endorsement.